Uncategorized

Know Before You File: Using Patent Landscape Analysis to Drive Go/No-Go Decisions in Generic and Biosimilar Drug Development

Generic and biosimilar development is a high-stakes game of timing, risk, and capital allocation. Yet many teams still make go/no-go decisions with incomplete visibility—treating patent landscapes as a compliance checkbox instead of a strategic decisio…

Know Before You File: Using Patent Landscape Analysis to Drive Go/No-Go Decisions in Generic and Biosimilar Drug Development Read Post »

Uncategorized

Own the Clock: How Pharma Companies Extract Maximum Value from Patent Term Extensions and Secondary Patents

Pharma doesn’t just “own” a drug patent—it often extends control over time.
That’s the core tension behind the industry’s playbook for maximizing value from patent term extensions and secondary patents. In a world where blockbuster revenue is measured …

Own the Clock: How Pharma Companies Extract Maximum Value from Patent Term Extensions and Secondary Patents Read Post »

Biotechblog
Scroll to Top